Kearns, Pamela <br/><br/>
Phase 1-2 safety, efficacy and pharmacokinetic study of decitabine in sequential administration with cytarabine in children with relapsed or refractory acute myeloid leukaemia.  [electronic resource] 

 -  British journal of haematology  08 2019 
 - e7-e11 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Letter; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1365-2141 
<br/><br/><label>Standard No.: </label>10.1111/bjh.15847  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Child<br/>Child, Preschool<br/>Cytarabine--administration & dosage<br/>Decitabine--administration & dosage<br/>Female<br/>Humans<br/>Infant<br/>Leukemia, Myeloid, Acute--drug therapy<br/>Male<br/>Neoplasm Recurrence, Local<br/>Treatment Outcome